Axsome Therapeutics, Inc.(AXSM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AXSM Axsome Therapeutics, Inc.

已收盘 09-17 16:00:00 EDT

90.94

-1.47

-1.59%

盘后90.94

+0.000.00%

19:11 EDT

最高93.27	最低89.56	成交量44.86万
今开92.86	昨收92.41	日振幅4.01%
总市值43.65亿	流通市值32.53亿	总股本4,800万
成交额4,093万	换手率1.25%	流通股本3,577万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"AXSM","market":"US","secType":"STK","nameCN":"Axsome Therapeutics, Inc.","latestPrice":90.94,"timestamp":1726603200000,"preClose":92.41,"halted":0,"volume":448625,"hourTrading":{"tag":"盘后","latestPrice":90.94,"preClose":90.94,"latestTime":"19:11 EDT","volume":24442,"amount":2222743.54,"timestamp":1726614666160},"delay":0,"floatShares":35773515,"shares":48000205,"eps":-6.517167,"marketStatus":"已收盘","marketStatusCode":5,"change":-1.47,"latestTime":"09-17 16:00:00 EDT","open":92.86,"high":93.27,"low":89.56,"amount":40925344.56875,"amplitude":0.040147,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.517167,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1726646400000},"adr":0,"listingDate":1447909200000,"adjPreClose":92.41,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":92.86,"preClose":92.41,"latestTime":"09:29 EDT","volume":470,"amount":43484.780699999996,"timestamp":1726579799999},"postHourTrading":{"tag":"盘后","latestPrice":90.94,"preClose":90.94,"latestTime":"19:11 EDT","volume":24442,"amount":2222743.54,"timestamp":1726614666160},"volumeRatio":1.359611,"impliedVol":0.4067,"impliedVolPercentile":0.1865},"requestUrl":"/m/hq/s/AXSM/wiki","defaultTab":"wiki","newsList":[{"id":"2460069588","title":"Axsome Therapeutics, Inc.盘中异动 临近收盘大幅上涨5.01%报90.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460069588","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460069588?lang=zh_cn&edition=full","pubTime":"2024-08-20 03:54","pubTimestamp":1724097243,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日03时54分，Axsome Therapeutics, Inc.股票出现异动，股价大幅拉升5.01%。截至发稿，该股报90.49美元/股，成交量52.7305万股，换手率1.10%，振幅4.94%。Axsome Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.11%。其相关个股中，Alzamend Neuro, Inc.、Nucana Plc、Virax Biolabs Group Limited涨幅较大，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为9548.22%、3942.73%、1349.48%，振幅较大的相关个股有Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Nucana Plc，振幅分别为456.88%、220.18%、200.00%。Axsome Therapeutics, Inc.公司简介：Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082003540398e356a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082003540398e356a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AXSM","BK4585","BK4505","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2458682519","title":"Axsome Therapeutics, Inc.2024财年第二财季实现净利润-79.35百万美元，同比减少18.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458682519","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458682519?lang=zh_cn&edition=full","pubTime":"2024-08-11 00:20","pubTimestamp":1723306822,"startTime":"0","endTime":"0","summary":"8月11日，Axsome Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-79.35百万美元，同比减少18.13%；其中营业收入为87.17百万美元，同比增加86.66%，每股基本收益为-1.67美元。机构评级：截至2024年8月11日，当前有17家机构对Axsome Therapeutics, Inc.目标价做出预测，其中目标均价为124.35美元，其中最低目标价为100.00美元，最高目标价为180.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240811002025958e759e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240811002025958e759e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AXSM","LENZ"],"gpt_icon":0},{"id":"2457044026","title":"美国研究综述-Actinium Pharmaceuticals、Albemarle、ArcBest","url":"https://stock-news.laohu8.com/highlight/detail?id=2457044026","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457044026?lang=zh_cn&edition=full","pubTime":"2024-08-06 20:56","pubTimestamp":1722949016,"startTime":"0","endTime":"0","summary":"    路透8月6日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Actinium Pharmaceuticals、Albemarle 和 ArcBest。要点   * Actinium Pharmaceuticals Inc   ：JonesTrading将其交易价格从26美元下调至9美元 * Albemarle   ：Baird将其评级下调至中性，目标价从102美元下调至85美元 * ArcBest Corp   ：Stephens 将目标价从 145 美元下调至 130 美元 * Crispr Therapeutics AG   ：Leerink Partners将目标价从80美元下调至68美元 * Warrior Met Coal Inc   ：杰富瑞将目标价从85美元下调至78美元 以下是路透周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTRE","AEE","AMRC","CDNS","AN","ANAB","BK","AHR","CABO","CBT","BKH","LU0648001328.SGD","AKYA","CWT","BK4129","ARCB","BIIB","ALB","LU1978683503.SGD","ATIP","AMWL","LU0354030511.USD","LNT","LU1323610961.USD","AEP","ETNB","AIG","AQMS","BN","ALX","BK4231","AES","AXSM","IE00B1XK9C88.USD","LU","IE00BKDWB100.SGD","ADUS","APO","BMRN","ARCH","CG","ALL","BCRX","ASPN","ALHC","BK4519"],"gpt_icon":1},{"id":"1110603598","title":"异动解读 | Axsome Therapeutics盘前大跌17% 财报亏损扩大营收增长放缓","url":"https://stock-news.laohu8.com/highlight/detail?id=1110603598","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110603598?lang=zh_cn&edition=full","pubTime":"2024-08-05 22:14","pubTimestamp":1722867298,"startTime":"0","endTime":"0","summary":"生物制药公司Axsome Therapeutics今日盘前股价大跌17.08%,引发市场广泛关注。根据公司最新公布的2024年第二季度财报,该公司调整后每股亏损1.67美元,远高于去年同期的1.54美元盈利,也未达到分析师平均预期的1.33美元亏损。财报显示,Axsome Therapeutics第二季度营收同比增长88%至8652万美元,但也低于分析师预期的8692万美元。公司本季度净亏损高达7935万美元,股价今年迄今上涨6.1%。分析人士指出,Axsome Therapeutics本季度亏损扩大、营收增长放缓,未达预期,这可能是导致其股价大跌的主要原因。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXSM"],"gpt_icon":0},{"id":"2457677593","title":"Axsome Therapeutics, Inc.股价重挫10.91% 市值跌3.9亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457677593","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457677593?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:36","pubTimestamp":1722864966,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时36分，Axsome Therapeutics, Inc.股票出现波动，股价快速跳水10.91%。Axsome Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.68%。其相关个股中，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Zevra Therapeutics, Inc.、Okyo Pharma Ltd Com Npv 涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为1030.25%、44.71%、13.93%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.、Portage Biotech Inc.，振幅分别为19.19%、17.59%、16.29%。Axsome Therapeutics, Inc.公司简介：Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052136069f107175&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052136069f107175&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AXSM","BK4585","BK4139","LENZ","BK4505"],"gpt_icon":0},{"id":"2457572060","title":"Axsome Therapeutics Inc 报告截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2457572060","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457572060?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:32","pubTimestamp":1722864744,"startTime":"0","endTime":"0","summary":"   * Axsome Therapeutics Inc   报告了截至6月底的季度调整后每股亏损1.67美元，低于去年同期的每股收益1.54美元。华尔街预期为每股亏损 1.67 美元至-97 美分。* 营收同比增长 88%，达到 8652 万美元；分析师预期为 8692 万美元。* Axsome Therapeutics Inc公布的本季度每股收益为亏损1.67美元。* 该公司一季度亏损 7935 万美元。* Axsome Therapeutics Inc本季度股价上涨了4.9%，今年迄今为止上涨了6.1%。8月5日 - 预测变化   * 过去三个月，分析师的平均盈利预期下降了约 7.2%。华尔街对 Axsome Therapeutics Inc 的 12 个月目标价中位数为 117.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AXSM","BK4585","BK4139","LENZ","BK4505"],"gpt_icon":0},{"id":"2457728425","title":"Axsome Therapeutics(AXSM.US)：2024年Q2财报实现营收8716.6万美元，前值为4670万美元，预期值为8692万美元；","url":"https://stock-news.laohu8.com/highlight/detail?id=2457728425","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457728425?lang=zh_cn&edition=full","pubTime":"2024-08-05 19:09","pubTimestamp":1722856155,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","BK4139","AXSM","BK4505","BK4585","BK4007"],"gpt_icon":0},{"id":"2456230174","title":"Axsome Therapeutics Inc    预计每股亏损 1.33 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456230174","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456230174?lang=zh_cn&edition=full","pubTime":"2024-08-03 01:06","pubTimestamp":1722618411,"startTime":"0","endTime":"0","summary":"   * Axsome Therapeutics Inc    将于8月5日公布截至2024年6月30日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，16位分析师的平均预期显示，这家总部位于纽约的公司的营收有望从去年同期的4602万美元增长88.9%，达到8692.2万美元。* LSEG分析师对Axsome Therapeutics Inc的平均预期为每股亏损1.33美元。* 华尔街对 Axsome Therapeutics Inc 的 12 个月目标价中位数为 117.50 美元，高于其上次收盘价 86.01 美元。8月2日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXSM","LENZ"],"gpt_icon":0},{"id":"2453792825","title":"美国研究综述-Align Technology、McKesson、Schneider National","url":"https://stock-news.laohu8.com/highlight/detail?id=2453792825","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453792825?lang=zh_cn&edition=full","pubTime":"2024-07-22 23:31","pubTimestamp":1721662281,"startTime":"0","endTime":"0","summary":"    路透7月22日 - 华尔街证券分析师周一调整了对 Align Technology、McKesson 和 Schneider National 等几家美国上市公司的评级和目标价。* McKesson Corp   ：瑞银将目标价从630美元上调至670美元              * Schneider National   ：美国银行全球研究将其评级从 \"中性 \"下调至 \"跑输大市\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXSM","OZK","TXG","LU0476273544.USD","AN","AES","AMD","BAC","BKU","LU0149725797.USD","BMI","APA","ANAB","ALV","ADC","BRBR","ALX","BCML","CMA","AEP","BCBP","LU1244550221.USD","LU2242652126.USD","PPG","ANF","ALGN","ARCB","AXP","AAL","IE0034235188.USD","BANF","BANR","BGS","BHP","BE","ACM","AUGX","AVBP","PINE","LU1880398554.USD","LU","BHLB","AA","BNTC","AGCO","AMZN","AXL","AMRC","BK4141","AGEN"],"gpt_icon":0},{"id":"2452050724","title":"Axsome Therapeutics, Inc.盘中异动 急速上涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452050724","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452050724?lang=zh_cn&edition=full","pubTime":"2024-07-20 00:12","pubTimestamp":1721405536,"startTime":"0","endTime":"0","summary":"北京时间2024年07月20日00时12分，Axsome Therapeutics, Inc.股票出现异动，股价急速拉升5.09%。Axsome Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Axsome Therapeutics, Inc.公司简介：Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。消息层面，截至00时12分，《花旗维持Axsome Therapeutics买入评级，维持目标价125美元》资讯为影响Axsome Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240720001216af93331f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240720001216af93331f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AXSM","LENZ","BK4585","BK4505","BK4139"],"gpt_icon":0},{"id":"2444368210","title":"Axsome Therapeutics, Inc.盘中异动 快速下挫5.04%报72.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444368210","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444368210?lang=zh_cn&edition=full","pubTime":"2024-06-20 21:48","pubTimestamp":1718891302,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日21时48分，Axsome Therapeutics, Inc.股票出现波动，股价大幅下跌5.04%。Axsome Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Clearmind Medicine Inc.、Geovax Labs, Inc.、Trevena, Inc.较为活跃，换手率分别为371.24%、172.08%、136.82%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Trevena, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为65244.36%、36.51%、30.23%。Axsome Therapeutics, Inc.公司简介：Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620214822941efd6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620214822941efd6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LENZ","BK4139","AXSM","BK4505","BK4007"],"gpt_icon":0},{"id":"2442964392","title":"BUZZ-Axsome Therapeutics 在 Culper Research 披露空头头寸后下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2442964392","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442964392?lang=zh_cn&edition=full","pubTime":"2024-06-11 22:08","pubTimestamp":1718114925,"startTime":"0","endTime":"0","summary":"    6月11日 - ** Axsome Therapeutics    股价下跌 7.47% 至 66.44 美元** Culper Research披露了该制药公司的空头头寸*称该公司的重度抑郁障碍药物 Auvelity 的上市 \"得益于与可疑邮购药店之间未披露的委托交易，这些药店破坏了事先授权，夸大了处方数量和报告收入\" * \"这引起了反回扣的质疑\"。** 我们认为，这引发了反回扣问题、虚假索赔问题和收入确认问题。** Axsome 没有立即回应路透的置评请求** Auvelity 于 2022 年获批 ，2024 年第一季度的销售额为 5340 万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4585","BK4139","BK4007","BUZZ","LENZ","AXSM"],"gpt_icon":0},{"id":"2442739972","title":"Axsome Therapeutics, Inc.盘中异动 早盘急速跳水6.96%报66.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442739972","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442739972?lang=zh_cn&edition=full","pubTime":"2024-06-11 21:31","pubTimestamp":1718112693,"startTime":"0","endTime":"0","summary":"北京时间2024年06月11日21时31分，Axsome Therapeutics, Inc.股票出现波动，股价大幅跳水6.96%。Axsome Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、180 Life Sciences Corp C/Wts 07/11/2025、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Clearmind Medicine Inc.、Processa Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为129.17%、51.85%、26.27%，振幅较大的相关个股有康乃德生物、Trevi Therapeutics, Inc.、Calidi Biotherapeutics, Inc.，振幅分别为10.76%、9.88%、8.88%。Axsome Therapeutics, Inc.公司简介：Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406112131339f311ca7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406112131339f311ca7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","AXSM","BK4505","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2434766876","title":"Axsome Therapeutics, Inc.2024财年第一财季实现净利润-68.36百万美元，同比减少509.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434766876","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434766876?lang=zh_cn&edition=full","pubTime":"2024-05-12 00:22","pubTimestamp":1715444570,"startTime":"0","endTime":"0","summary":"3月31日，Axsome Therapeutics, Inc.公布财报，公告显示公司2024财年第一财季净利润为-68.36百万美元，同比减少509.27%；其中营业收入为75.00百万美元，同比减少20.70%，每股基本收益为-1.44美元。机构评级：截至2024年3月31日，当前有15家机构对Axsome Therapeutics, Inc.目标价做出预测，其中目标均价为124.60美元，其中最低目标价为97.00美元，最高目标价为190.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405120022538af9301c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405120022538af9301c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","AXSM"],"gpt_icon":0},{"id":"2433853733","title":"花旗：维持Axsome Therapeutics(AXSM.US)评级，由买入调整至买入评级, 目标价由127.00美元调整至125.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433853733","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433853733?lang=zh_cn&edition=full","pubTime":"2024-05-08 01:24","pubTimestamp":1715102694,"startTime":"0","endTime":"0","summary":"花旗：维持Axsome Therapeutics(AXSM.US)评级，由买入调整至买入评级, 目标价由127.00美元调整至125.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050801245687dd2aed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050801245687dd2aed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AXSM","LENZ"],"gpt_icon":0},{"id":"2433424126","title":"Axsome Therapeutics(AXSM.US)：2024年Q1财报实现营收7499.9万美元，前值为9457.6万美元，预期值为7347万美元；","url":"https://stock-news.laohu8.com/highlight/detail?id=2433424126","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433424126?lang=zh_cn&edition=full","pubTime":"2024-05-06 19:57","pubTimestamp":1714996663,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","LENZ","BK4139","AXSM","BK4505","BK4007"],"gpt_icon":0},{"id":"2432907276","title":"Axsome Therapeutics Inc    预计每股亏损 1.20 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432907276","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432907276?lang=zh_cn&edition=full","pubTime":"2024-05-03 23:48","pubTimestamp":1714751294,"startTime":"0","endTime":"0","summary":"   * Axsome Therapeutics Inc    将于5月6日公布截至2024年3月31日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，14位分析师的平均预期显示，这家总部位于纽约的公司的营收预计将从去年同期的9458万美元下降22.5%，至7329.5万美元。* LSEG分析师对Axsome Therapeutics Inc的平均预期为每股亏损1.20美元。* 华尔街对Axsome Therapeutics Inc的12个月目标价中位数为115.00美元，高于其最新收盘价74.19美元。5月3日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","AXSM"],"gpt_icon":0},{"id":"2431865675","title":"Axsome Therapeutics, Inc.盘中异动 早盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431865675","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2431865675?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:35","pubTimestamp":1714397720,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时35分，Axsome Therapeutics, Inc.股票出现异动，股价快速拉升5.05%。Axsome Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Axsome Therapeutics, Inc.公司简介：Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。该信息摘要如下：大摩：上调Axsome Therapeutics评级，由持股观望调整至增持评级, 目标价由90.00美元调整至115.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292135207a572873&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292135207a572873&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AXSM","BK4505","BK4007","LENZ","BK4585"],"gpt_icon":0},{"id":"2431887199","title":"大摩：上调Axsome Therapeutics(AXSM.US)评级，由持股观望调整至增持评级, 目标价由90.00美元调整至115.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2431887199","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2431887199?lang=zh_cn&edition=full","pubTime":"2024-04-29 17:35","pubTimestamp":1714383352,"startTime":"0","endTime":"0","summary":"大摩：上调Axsome Therapeutics(AXSM.US)评级，由持股观望调整至增持评级, 目标价由90.00美元调整至115.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042917355687be9471&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042917355687be9471&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","AXSM"],"gpt_icon":0},{"id":"2431576884","title":"大摩：上调Axsome Therapeutics(AXSM.US)评级，由持股观望调整至增持评级, 目标价由90.00美元调整至115.","url":"https://stock-news.laohu8.com/highlight/detail?id=2431576884","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2431576884?lang=zh_cn&edition=full","pubTime":"2024-04-29 17:26","pubTimestamp":1714382811,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1363072403.SGD","BK4139","LU1989772840.SGD","BK4504","LU1668664300.SGD","BK4581","LU0106831901.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4127","LU0320765646.SGD","LU0971096721.USD","AXSM","LU1074936037.SGD","LU1989772923.USD","LU0098860793.USD","BK4505","BK4007","BK4585","BK4588","BK4534","LENZ","LU1162221912.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.axsome.com","stockEarnings":[{"period":"1week","weight":-0.0179},{"period":"1month","weight":0.0724},{"period":"3month","weight":0.2156},{"period":"6month","weight":0.172},{"period":"1year","weight":0.2279},{"period":"ytd","weight":0.1611}],"compareEarnings":[{"period":"1week","weight":0.0301},{"period":"1month","weight":0.0154},{"period":"3month","weight":0.0262},{"period":"6month","weight":0.0814},{"period":"1year","weight":0.2695},{"period":"ytd","weight":0.1842}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Axsome Therapeutics, Inc.成立于2012年1月。该公司是一家临床阶段的生物制药企业，开发新的治疗疼痛和其他中枢神经系统或中枢神经系统，疾病管理。通过专注于这一治疗领域，他们正在解决显著和不断增长的市场，其中目前的治疗选择是有限或不充分的。他们的目标是成为一个完全集成的生物制药公司开发和商业化的拓展提供给医护人员的治疗方案，提高生活疼痛和其他中枢神经系统疾病患者的生命分化疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":0.061264},{"month":2,"riseRate":0.111111,"avgChangeRate":-0.054934},{"month":3,"riseRate":0.333333,"avgChangeRate":0.073863},{"month":4,"riseRate":0.777778,"avgChangeRate":0.172294},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.051837},{"month":6,"riseRate":0.666667,"avgChangeRate":0.138679},{"month":7,"riseRate":0.555556,"avgChangeRate":-0.030202},{"month":8,"riseRate":0.555556,"avgChangeRate":0.036801},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.01871},{"month":10,"riseRate":0.5,"avgChangeRate":0.002414},{"month":11,"riseRate":0.625,"avgChangeRate":0.164861},{"month":12,"riseRate":0.777778,"avgChangeRate":0.225168}],"exchange":"NASDAQ","name":"Axsome Therapeutics, Inc.","nameEN":"Axsome Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Axsome Therapeutics, Inc.(AXSM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Axsome Therapeutics, Inc.(AXSM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Axsome Therapeutics, Inc.,AXSM,Axsome Therapeutics, Inc.股票,Axsome Therapeutics, Inc.股票老虎,Axsome Therapeutics, Inc.股票老虎国际,Axsome Therapeutics, Inc.行情,Axsome Therapeutics, Inc.股票行情,Axsome Therapeutics, Inc.股价,Axsome Therapeutics, Inc.股市,Axsome Therapeutics, Inc.股票价格,Axsome Therapeutics, Inc.股票交易,Axsome Therapeutics, Inc.股票购买,Axsome Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Axsome Therapeutics, Inc.(AXSM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Axsome Therapeutics, Inc.(AXSM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}